Max Reiboldt joins Mark to discuss private equity deals in the healthcare industry. Max and Mark review the recent private equity activity in healthcare and how these deals impact the market.

Contact Information

Subscribe to our feed in Apple Podcasts, Google Podcasts, Spotify, or your preferred podcast provider. Like what you hear? Leave a review! Not there? Let us know!

We welcome all feedback from our listeners. Please submit questions on any of the topics we discuss or questions about issues that interest you. You can also recommend topics for future episodes.

• Email us: [email protected]
• Connect with us on LinkedIn: Coker Group Company Page
• Follow us on Twitter: @cokergroup
• Follow us on Instagram: @cokergroup

Episode Synopsis

In recent years, several private equity firms have been involved with hospital and/or physician transactions. Mark and Max examine the reasons private equity firms are attracted to the healthcare industry, which leads to the question, how are these deals impacting the healthcare market?

With private equity involvement, the idea is to maximize downstream value. Mark and Max discuss why these deals are attractive to healthcare organizations and certain characteristics with which healthcare organizations should be familiar.

Extras

Article: Private equity infuses healthcare with $63B investment

Article: The Next Stage of Evolution in Physician Practice Transactions: Can hospitals compete with private equity in attracting physician group deals?

Bio: Mark Reiboldt

Bio: Max Reiboldt